|
Market Closed -
Nasdaq
16:00:00 2026-11-10 EST
|
5-day change | 1st Jan Change | ||
| 69.45 USD | +0.99% |
|
+4.59% | +79.74% |
| 11-04 | Royalty Pharma plc, Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-04 | Royalty Pharma plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROYALTY PHARMA PLC | Other Pharmaceuticals | +0.99% | +4.59% | +79.74% | +80.20% | +67.03% | 30.92B |  | | |
- Stock Market
- Stocks
- RPRX Stock
- Charts Royalty Pharma plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
